These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35477673)

  • 1. Association of Phosphate-Containing versus Phosphate-Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy.
    Thompson Bastin ML; Stromberg AJ; Nerusu SN; Liu LJ; Mayer KP; Liu KD; Bagshaw SM; Wald R; Morris PE; Neyra JA
    Clin J Am Soc Nephrol; 2022 May; 17(5):634-642. PubMed ID: 35477673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Phosphate Containing Solutions with Incident Hypophosphatemia in Critically Ill Patients Requiring Continuous Renal Replacement Therapy.
    Thompson Bastin ML; Adams PM; Nerusu S; Morris PE; Mayer KP; Neyra JA
    Blood Purif; 2022; 51(2):122-129. PubMed ID: 33915554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions.
    Di Mario F; Regolisti G; Maggiore U; Pacchiarini MC; Menegazzo B; Greco P; Maccari C; Zambrano C; Cantarelli C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2022 Nov; 37(12):2505-2513. PubMed ID: 35481705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults.
    Song YH; Seo EH; Yoo YS; Jo YI
    Ren Fail; 2019 Nov; 41(1):72-79. PubMed ID: 30909778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study.
    Gould DW; Doidge J; Sadique MZ; Borthwick M; Hatch R; Caskey FJ; Forni L; Lawrence RF; MacEwen C; Ostermann M; Mouncey PR; Harrison DA; Rowan KM; Young JD; Watkinson PJ
    Health Technol Assess; 2022 Feb; 26(13):1-58. PubMed ID: 35212260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Hypophosphatemia and Outcomes during Continuous Renal Replacement Therapy.
    Hendrix RJ; Hastings MC; Samarin M; Hudson JQ
    Blood Purif; 2020; 49(6):700-707. PubMed ID: 32320987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid Overload Associates With Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy.
    Woodward CW; Lambert J; Ortiz-Soriano V; Li Y; Ruiz-Conejo M; Bissell BD; Kelly A; Adams P; Yessayan L; Morris PE; Neyra JA
    Crit Care Med; 2019 Sep; 47(9):e753-e760. PubMed ID: 31162196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.
    Shi Z; Xie H; Wang P; Zhang Q; Wu Y; Chen E; Ng L; Worthington HV; Needleman I; Furness S
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008367. PubMed ID: 23939759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Institutional Change in Continuous Renal Replacement Therapy: Nutrition Support Team Resolves Resultant Severe Hypophosphatemia.
    Busch RA; Curtis CS; Kight CE; Leverson GE; Ma Y; Maursetter L; Kudsk KA
    Nutr Clin Pract; 2017 Apr; 32(2):245-251. PubMed ID: 29927525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower mean phosphate independently predicts mortality in critically ill patients: Results from a prospective cohort study.
    Lima W; Calderaro DC; Passos R; Côrte M; Leal JA; Mayrink MO; Ferreira G
    J Crit Care; 2023 Jun; 75():154273. PubMed ID: 36739201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies.
    Pistolesi V; Zeppilli L; Fiaccadori E; Regolisti G; Tritapepe L; Morabito S
    J Nephrol; 2019 Dec; 32(6):895-908. PubMed ID: 31515724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of electrolyte-rich dialysate during continuous renal replacement therapy on serum phosphate and potassium in ICU patients.
    Cho A; Lee YK; Park HC
    PLoS One; 2020; 15(9):e0238867. PubMed ID: 32915900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictions of Serum Phosphate Concentration during Continuous Renal Replacement Therapy Using a Steady-State Mass Balance Model.
    Leypoldt JK; Echeverri J; Harenski K; Singh K
    Blood Purif; 2024; 53(1):40-48. PubMed ID: 37926075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Serum Phosphate Derangement With Mortality in Patients on Continuous Renal Replacement Therapy.
    Thongprayoon C; Radhakrishnan Y; Cheungpasitporn W; Petnak T; Qureshi F; Mao MA; Kashani KB
    Can J Kidney Health Dis; 2022; 9():20543581221114697. PubMed ID: 35923184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of different hemodiafiltration solutions on ionemia in long-term CRRT.
    Nalesso F; Garzotto F; Cattarin L; Innico G; Gobbi L; Calò LA
    Int J Artif Organs; 2021 Nov; 44(11):807-815. PubMed ID: 34472996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity of continuous renal replacement therapy for acute kidney injury.
    Fayad AI; Buamscha DG; Ciapponi A
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD010613. PubMed ID: 27699760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between continuous renal replacement therapy and 28-day mortality of critically ill patients with COVID-19 receiving mechanical ventilation.
    Xu X; Liu K; Cheng P; Huang Y; Huang C; Wu W; Xing C; Mao H; Liu Y
    Clin Nephrol; 2021 Oct; 96(4):207-215. PubMed ID: 34236306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No difference in mechanical ventilation-free hours in critically ill patients who received intravenous, oral, or enteral phosphate replacement.
    Lemon SJ; Zack SD; Voils SA
    J Crit Care; 2017 Jun; 39():31-35. PubMed ID: 28152386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Institutional Change in Continuous Renal Replacement Therapy.
    Busch RA; Curtis CS; Kight CE; Leverson GE; Ma Y; Maursetter L; Kudsk KA
    Nutr Clin Pract; 2017 Apr; 32(2):245-251. PubMed ID: 27589256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.